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CHAPTER 5
Evaluation of functional nerve recovery after reconstruction
with a poly(DL-lactide-ε-caprolactone) nerve guide, filled withmodified denatured muscle tissue
MF Meek,1 WFA den Dunnen,2 JM Schakenraad,3 PH Robinson, FRCS1
1 Department of Plastic Surgery, University Hospital Groningen,
  Groningen, The Netherlands
2 Department of Pathology, University Hospital Groningen,
  Groningen, The Netherlands
3 KEMA Medical,





The aim of this study was to compare the speed of functional nerve recovery after
reconstruction with a biodegradable p(DLLA-ε-CL) nerve guide, as filled with ei-ther modified denatured muscle tissue (MDMT) or phosphate-buffered saline (PBS).To evaluate both motor and sensory nerve recovery, walking track analysis and
electrostimulation tests were carried out after implantation periods, ranging from3-15 weeks. Functional nerve recovery after reconstruction of a 15 mm nerve gap,
with a biodegradable p(DLLA-ε-CL) nerve guide filled with modified denaturedmuscle tissue, was slightly faster, compared with nerve reconstruction of a 10 mmgap with a biodegradable p(DLLA-ε-CL) nerve guide filled with PBS. We conclude
that our experiments have demonstrated that the use of MDMT increases the speedof recovery after reconstruction of a nerve gap with a p(DLLA-ε-CL) biodegradable
nerve guide. Furthermore, the use of MDMT might open perspectives for repair oflonger nerve gaps.
Introduction
The most widely-used technique for
bridging nerve gaps is the use of autolo-gous nerve grafts. This technique, how-ever, has some disadvantages: harvest-
ing of the graft causes sensory deficit atthe donor site and the risk of neuroma
formation there. To eliminate these prob-lems, many alternative techniques, suchas the use of biodurable nerve guides,
have been developed to bridge a nervegap.1-6 However, biodurable biomaterials
remain in situ as a foreign body, poten-tially causing a chronic foreign bodyreaction with excessive scar tissue for-
mation, resulting in constriction of theregenerating nerve, and ultimately limi-
ting recovery of nerve function (e.g., se-condary nerve impairment).1,2,7Biodegradable nerve guides provide a
successful alternative. The idea behind
the use of biodegradable nerve guides is,that the nerve guide directs the outgro-wing nerve fibers towards the distal nerve
stump, while preventing neuroma forma-
tion and ingrowth of fibrous tissue intothe nerve gap. After serving these func-
tions, the nerve guide should graduallydegrade, without inducing scar tissue for-
mation. The use of a biodegradable nerveguide composed of an amorphous co-polymer of DL-lactide and ε-
caprolactone [p(DLLA-ε-CL)] hasproven to be successful.8-11 This nerve
guide degrades quickly and completelywithin 1 year,9 and nerve regenerationacross a 1 cm nerve gap was faster and
qualitatively better, compared with nerveregeneration through an autologous nerve
graft.10 Moreover, reconstruction withthis nerve guide showed good functionalnerve recovery.11 However, in all these
previous experiments, nerve gaps of 1 cmin the sciatic nerve of rats were bridged.
To bridge a nerve gap of several centi-meters (a more realistic point of view inthe clinical situation), the addition of
nerve growth stimulation factors will benecessary. The addition of one of these
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factors can be of special importance innerve regeneration through a nerve guideof several centimeters, since the maxi-
mum gap length that can be successfullyreconstructed with a nerve guide in the
rat is 2 cm.12 Several researchers have al-ready studied the influence of growth fac-tors,13 extracellular matrix molecules,14-
16 and freeze-thawed muscle tissue on pe-ripheral nerve regeneration. Most factors
positively influence peripheral nerveregeneration.17 The use of denaturedmuscle tissue inside a nerve guide is very
promising, since the longitudinally ori-ented basal lamina of the muscle tissue
will direct the outgrowing nerve fiberstowards the distal nerve stump by func-tioning as a scaffold for the outgrowing
nerves.18 In addition, the basal laminacontains both collagen type IV and lami-
nin, which are known to enhance theoutgrowth and regeneration of peripheral
nerve fibers.19 The nerve guide preventsneuroma formation and the ingrowth offibrous tissue into the nerve gap. Due to
the presence of muscle tissue inside thenerve guide, there is less tendency for the
nerve guide to collapse.20 Recently weevaluated different preparation tech-niques of denatured muscle tissue,21 aim-
ing at an open structure of the extracellu-lar matrix (ECM) and an intact basement
membrane. The aim of this study was toevaluate the speed of functional nerve re-covery after reconstruction with a
biodegradable p(DLLA-ε-CL) nerveguide, filled with modified denatured
muscle tissue (MDMT).
Materials and Methods
Preparation of Nerve GuidesThe biodegradable nerve guides in this
study were composed of a copolymer of50% DL-lactide and 50% ε-caprolactone.The lactide component contained 85% L-
lactide (LLA) and 15% D-lactide (DLA).The nerve guide was made by a dip-coa-
ting technique, which is described in de-tail by den Dunnen et al.8 After prepara-tion, the nerve guides were stored in
100% ethanol at 4 oC. Before implanta-tion, the nerve guides were first washed
in 0.1 M sterile phosphate-buffered sa-line (PBS) at room temperature, and thenfilled with 0.1 M sterile PBS (group A),
or with modified denatured muscle tis-sue (group B).
Preparation of the Denatured MuscleTissue
Muscle tissue specimens were harvestedfrom the back of male Wistar rats, stored
at -20 oC for 24 hr, and then placed indemineralized water at 4 oC for 24 hr.
These freeze-thawed (denatured) muscletissue specimens were then treated usingthe following technique: the sample was
first placed in 16% acetic acid, at roomtemperature (RT) for 30 min, then placed
under vacuum (10 mBar) (Brand RS-4,Wertheim, Germany) for 1 hr, and finallyplaced in 0.1 M phosphate buffer at RT
for 1 hr to clean the muscle tissue (Fig.1). The preparation of modified dena-
tured muscle tissue is described in moredetail by Meek et al.21 This MDMT wasthen cut to the appropriate dimensions
and put into the nerve guide, with thebasal lamina oriented longitudinally,
leaving approximately 1.5 mm at bothnerve guide ends.
Surgical ProceduresMale Wistar rats (n = 30), weighing ap-
proximately 250 g, were premedicated
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Fig. 1. Illustration (A) and cryoscanning electron micrographs (cry-SEM) (B) showing preparation ofmodified denatured muscle tissue obtained from the back of the rat. B1, B2: Untreated (normal)
muscle tissue. B3, B4: Denatured muscle tissue shows that muscle fibers are swollen. B5, B6: Modi-
fied denatured muscle tissue shows that the original muscle-fiber shape has disappeared and thatstriations are no longer present. Furthermore, modified denatured muscle tissue shows a wider
extracellular matrix. E, extracellular matrix; MFI, muscle fiber; My, myofibril. Bars in B1, B3 andB5, 4.5 µm. Bars in B2, B4 and B6, 0.3 µm.
    A
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   B
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with atropine (0.25 mg/kg body weight)and anesthetized with 1% isoflurane(Forene®) and  O2/N2O. The left sciaticnerve was exposed through a superficialgluteal muscle-splitting incision. In group
A, a 7 mm segment was then resected,leaving a gap of about 10 mm due toretraction of the nerve ends. Continuity
was reestablished using a 12 mm nerveguide. Both the proximal and distal cut
ends of the sciatic nerve were telescopedinto the ends of the nerve guide and fixedwith a single 9-0 nylon epineural suture
[Auto Suture (ussc), MV 100-4 needle].In group B, a 12 mm nerve segment was
resected, leaving a gap of about 15 mmdue to retraction of the nerve stumps.Continuity was reestablished by interpo-
sing an 18 mm nerve guide, filled withMDMT (Fig. 1A). Both the proximal and
distal cut ends of the sciatic nerve weretelescoped into the ends of the nerve
guide and fixed with a single 9-0 nylonepineural suture [Auto Suture (ussc), MV100-4 needle]. Surgical procedures were
performed under an operation micro-scope (Zeiss OPMI-6, Weesp, The Ne-
therlands), and a sterile technique wasused throughout the procedure.We emphasize that in this study, we in-
tentionally chose to compare two differ-ent gap lengths. We chose to reconstruct
a 1.5 cm nerve gap with a nerve guidefilled with MDMT, in order to evaluatewhether a longer gap could be success-
fully bridged, and whether the resultsobtained after reconstruction using this
technique are comparable to those afterreconstruction of the “standard gaplength” (i.e., 1 cm) without MDMT,
which was evaluated in all previous stu-dies. 8-11,16,20,22-25
In our opinion, the addition of MDMT
inside a nerve guide (group B) would cre-ate a three-dimensional (3-D) structure,providing the possibility to reconstruct a
longer nerve gap. Therefore, a 50%longer nerve gap was chosen.
After surgery, the animals were housedin a temperature- and humidity-con-trolled room with 12 hr light cycles and
had access to standard rat food and wa-ter ad libitum. Good laboratory practice
(GLP) was observed, according to theNational Guidelines for Animal Welfare,comparable with the international rules
for animal experimentation (InternationalGuide on Animal Biomedical Research
and Ethical Code for Animal Experi-mentation of the Council for Internatio-nal Organization of Medical Sciences).
Walking Track Analysis
After 3, 5, 8, 12, and 15 weeks of im-plantation, walking track analysis was
carried out to evaluate motor-nerverecovery, as described in detail by Meeket al.11 In brief, the rats were first allowed
conditioning trials in a 8.2 x 42 cm wal-king track. Then photographic paper was
cut to the appropriate dimensions andplaced on the bottom of the track. Therat’s hind feet were dipped in film deve-
loper slightly thickened with glycerol.The rat was permitted to walk down the
track, leaving its hind feet prints on thephotographic paper. From the footprints,several measurements were obtained:
distance from the heel to the third toe,the print length (PL); distance from the
first to the fifth toe, the toe spread (TS);and distance from the second to thefourth toe, the intermediary toe spread
(ITS). All three measurements weretaken from the left operated foot as well
as the contralateral nonoperated foot. As
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a result, print length factor (PLF), toespread factor (TSF), and intermediary toespread factor (ITF) could be calcula-
ted.26,27 As a result, a sciatic function in-dex (SFI) could be derived as follows:26,27
SFI = -38.3 x PLF + 109.5 x TSF + 13.3x ITF -8.8An SFI of 0 is normal. An SFI of -100
indicates total impairment. To obtain sig-nificant data, several prints were mea-
sured for each rat. Sometimes severalwalks were required to obtain clear printmarks.
Electrostimulation Tests
After 3, 5, 8, 12, and 15 weeks of im-plantation, electrostimulation tests toevaluate sensory-nerve recovery were
carried out at three different places on thelateral side of the left (operated) foot-sole,
as described in detail by Meek et al.11 Inbrief, an electrical stimulator with an ad-
justable current between 0-1.0 mA wasused for this purpose. A healthy rat willimmediately withdraw its foot and spread
its toes when stimulated. The threshold,i.e., the lowest current causing this re-
flex, was evaluated. Furthermore, itshould be mentioned that with electro-stimulation tests, not only recovery of
sensory-nerve function (e.g., afferentnerve fibers) is tested, but actually the
reflex arc (e.g., afferent/sensory nervefibers + efferent/motor nerve fibers) of astimulus to the sensory receptor. Theo-
retically, it might be possible that sen-sory-nerve fibers are recovered while
motor-nerve fibers are not. No with-drawal reflex is then observed.




Reproducible walking track patternscould be measured for all rats. Preopera-
tive sciatic function indices for the testgroup did not differ from the controlvalue (Fig. 2A). As a control, the SFI for
a perfect functioning hindpaw (SFI = 0)was used. Group A: Nerve guides. The
first signs of motor-nerve recovery werealready observed after 5 weeks. After 12weeks, approximately 60% of the mo-
tor-nerve function was recovered. GroupB: Nerve guides + muscle. The first signs
of motor-nerve recovery were observedafter 3 weeks. During the evaluation pe-riod, the SFI increased with time. After
12 weeks the SFI was -43.4 (almost 60%recovery).
Electrostimulation Tests
The current (mA) necessary to cause awithdrawal reflex of the foot is outlinedin Figure 2B. The threshold of the con-
tralateral control-foot was 0.18 mA (= op-timal value). Group A: Nerve guides. In
the first 3 weeks after implantation of thenerve guide, the maximum current of 1.0mA was not enough to cause the reflex.
After 5 weeks, the first signs of sensory-nerve recovery could be observed. After
12 weeks, the threshold decreased to ap-
proximately 0.48 mA. Group B: Nerve
guides + muscle. After 3 weeks, the firstsigns of sensory-nerve recovery could
already be observed and the threshold de-creased sharply to 0.71 mA at 5 weeks.After 12 weeks, the threshold decreased
to 0.37 mA.




This study demonstrates that functionalnerve recovery after reconstruction of a
1.5 cm gap with a biodegradablep(DLLA-ε-CL) nerve guide filled with
MDMT is slightly faster, compared withthe reconstruction of a 1 cm gap with abiodegradable p(DLLA-ε-CL) nerve
guide filled with PBS only.The first signs of functional (motor and
sensory) nerve recovery in group A(nerve guide + PBS) could be observedafter 5 weeks of implantation, whereas
the first signs of functional nerve reco-very in group B (nerve guide + MDMT)
were already observed after 3 weeks. Theexact moment at which the first sign offunctional nerve recovery of group B
started must have been before our firstevaluation period (at 3 weeks). Further-
more, it can be observed (Fig. 2) that themotor- and sensory-nerve recovery in
group A was somewhat slower than ingroup B, although a 50% longer nervegap was reconstructed in group B. Com-
plete return of motor- and sensory-nervefunction in both groups was not reached
at the end of the evaluation period. How-ever, since the return of nerve functionstarted somewhat earlier in group B, it
might be concluded that the addition ofMDMT inside the nerve guides in group
B enhanced the onset and speed of nerveregeneration. The results obtained in thisstudy (recovery of functionality) can not
be directly related to speed and qualityof nerve regeneration. To evaluate this
relationship more deeply, light-mi-croscopy (LM), transmission-electron-microscopy (TEM), and morphometric
analysis of the axon regeneration processwill be necessary.
Fig. 2. A: Graph showing change in average sci-
atic function index (SFI) with time. Note that an
SFI of 0 is normal, whereas an SFI of -100 indi-cates total impairment. An increase of SFI in group
A can be observed after 5 weeks, whereas in groupB, an increase of SFI can already be observed 3
weeks after implantation. B: Graph showing
change in current, which is necessary to causewithdrawal reflex of the foot of the rat with time.
The nonoperated contralateral foot-sole served asa control. A decrease of current in group A can be
observed after 5 weeks, whereas in group B, a
decrease of current can already be observed 3weeks after implantation.
Group A, 10 mm nerve gap/12 mm nerve guidefilled with PBS; group B, 15 mm nerve gap/18
mm nerve guide filled with modified denatured
muscle tissue
formed, and showed that motor- and sen-sory-nerve recovery in both groups A andB were highly significant: in both cases
P < 0.001.
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The use of denatured muscle grafts forperipheral nerve repair was studied byGlasby et al.17 They reconstructed 3 cm
gaps in the ulnar nerve of primates. By 6months, normal function of the hand had
returned. Norris et al. 28 studied the useof denatured muscle grafts in a series ofhuman patients in order to span gaps in
digital nerves. Nerve gaps of 15-25 mmwere bridged. Evaluation of 3-11 months
after reconstruction showed almost com-plete sensory recovery in 7 out of 8 pa-tients. However, Stirrat et al.29 showed
no motor recovery in 7 patients after re-construction of major mixed nerves with
degenerated skeletal muscle. This maybe explained by the fact that by using onlyfreeze-thawed denatured autologous
muscle (without a nerve guide) to bridgea nerve gap, there is an increased risk that
nerve fibers will grow out of the muscletissue, thereby forming a neuroma-in-
continuity. In our opinion, the risks asstated should not be taken, with regardto clinical application of denatured
muscle tissue in patients with nerve inju-ries.
When autologous nerve grafts are usedfor the reconstruction of nerve gaps, re-generation of axons through these grafts
is thought to be guided by endoneurialtubes (e.g., Schwann cell basement mem-
branes).30 Modified denatured muscle tis-sue contains basement membranes thatcan function as a scaffold for regenera-
ting axons. The major non-collagenouscomponent of basement membranes is
laminin, which has neurite-promotingactivity,31 and stimulates Schwann cellmitosis.32,33 This might explain the better
functional nerve recovery in group B.In a previous study,22 it was suggested
that the idea behind the use of a thin-
walled nerve guide (i.e., less biomaterialand less swelling) was correct; however,additional mechanical support is then
needed. The nerve guide and basementmembranes direct the outgrowing nerve
fibers towards the distal stump, preventthe ingrowth of fibrous scar tissue, andprovide an optimal environment enriched
with factors to enhance and orient axonalregeneration. Furthermore, the risk that
nerve fibers will grow out of the muscletissue, thereby forming a neuroma-in-continuity, is prevented.
LM, TEM, and morphometric analysisof the axon regeneration process is now
being performed to evaluate whether theaddition of modified denatured muscletissue inside nerve guides enhances the
speed of nerve regeneration, as was sug-gested earlier. In the future, the effects
of other additives (NGF, B50) insidebiodegradable nerve guides on the speed
and quality of functional nerve recoveryand nerve regeneration will be evaluated.Appropriate applications of additives in-
side biodegradable nerve guides will notonly improve peripheral nerve regenera-
tion, but also allow a larger nerve gap tobe reconstructed by nerve entubulation.The latter is of extreme importance with
regard to the clinical application of biode-gradable nerve guides, because in the
clinical situation nerve gaps of severalcentimeters have to be bridged.Finally, we conclude that our experiments
have demonstrated that the use of MDMTincreases the speed of recovery after
reconstruction of a nerve gap with ap(DLLA-ε-CL) biodegradable nerveguide. Furthermore, the use of MDMT
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